WHO rules require manufacturers to put into practice a steady threat administration approach for sterility test isolators, which includes typical hazard assessments and the event of threat-primarily based Regulate techniques. Manufacturers seeking to implement these solutions ought to give strong validation knowledge to show their equivalence to pharmacopoeial methods. waiting for link from Forum Profiles (6)